Delivery Order SPE2DB25D3017-SPE2DB26FVGUM
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,715.77 by the Defense Logistics Agency on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,288.90 by the Defense Logistics Agency for BIKTARVY 30-120-15 mg tablets (30-count supply). The contract, awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,560.43 for BIKTARVY 50-200-25 mg tablets (30-count units) by the Defense Logistics Agency on September 9, 2025. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 10, 2025, with performance taking place at the company's Conshohocken facility. The award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $36,245.57 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive, firm fixed-price delivery order was placed under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency for $2,881.08 to supply Biktarvy 50-200-25 mg tablets (30-count units). The contract, which is a firm fixed price delivery order with no set-aside designation, was awarded on November 5, 2025, and is scheduled for completion by November 6, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for $87,877.92 to supply Biktarvy 50-200-25 mg tablets (30-count units), with an ultimate completion date of October 16, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $73,229.67 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract fulfilling federal pharmaceutical procurement requirements. The award was placed to AmerisourceBergen's Corporate Office located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,635.27, is set to be completed by August 13, 2025, and represents performance at the company's Conshohocken facility. The contract was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp received a delivery order contract award valued at $43,228.92 from the Defense Logistics Agency's Medical Supply Chain on September 25, 2025, with an ultimate completion date of September 26, 2025. The contract covers the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procurement. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,762.11 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30, with a firm fixed price structure and an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGUMDelivery Order
AmerisourceBergen Drug Corp has been awarded a competitively-awarded delivery order contract by the Defense Logistics Agency (DLA) for the supply of BIKTARVY 50-200-25 mg tablets in 30-count packages, valued at $45,147.47 with a firm fixed price structure. The contract is a non-set-aside award with an ultimate completion date of October 29, 2025, and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. This prime IDC, valued at $999,999,999.00 through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company's extensive federal contract portfolio with DLA demonstrates its capability to meet competitive procurement requirements while delivering diverse pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Delivery will be performed at the company's corporate office location in Conshohocken, PA 19428.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 10/28/25 |